Our work demonstrated that the biochemical changes induced by IDH mutation could be detected by the mean of RS and exploited in fresh tissue glioma biopsies to distinguish between IDH-MUT and IDH-WT tumors. This evidence concerns the gene IDH2 and central nervous system cancer.